IP Library Granted Patent US 8,901,045
Granted Patent B2
US 8,901,045 · App. 13/464,047 · Granted Dec 2, 2014

Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,901,045
App. No.
13/464,047
Granted
Dec 2, 2014
Kind
B2
Abstract

Methods useful in constructing libraries that collectively display and/or express members of diverse families of peptides, polypeptides or proteins and the libraries produced using those methods are disclose. Methods of screening those libraries and the peptides, polypeptides or proteins identified by such screens are also disclosed.

Claims (18)

1. A vector comprising:

(i) a DNA sequence encoding an antibody variable region linked to a fragment of a wild-type PIII anchor which does not mediate infection of phage particles; and

(ii) wild-type gene III;

wherein the nucleic acid sequence encoding the fragment of the wild-type pIII anchor differs from the wild-type gene III to an extent sufficient to reduce homologous recombination between the nucleic acid encoding the fragment of the wild-type PIII anchor and the wild-type gene III,

wherein all the codons in the nucleic acid encoding the fragment of the wild-type pIII anchor have at least one base change introduced per codon compared to the wild-type gene III.

2. The vector of claim 1 , wherein the DNA encodes a Fab.

3. The vector of claim 1 , wherein the DNA encodes heavy chain VHCH1.

4. The vector of claim 3 , wherein the heavy chain VHCH1 is linked to trpIII.

5. The vector of claim 1 , wherein the DNA encodes light chain VLCL.

6. The vector of claim 5 , wherein the light chain VLCL is linked to trpIII.

7. The vector of claim 1 , wherein the DNA encodes scFv.

8. The vector of claim 7 , wherein the scFv is VL-VH.

9. The vector of claim 7 , wherein the scFv is VH-VL.

10. The vector of claim 1 , wherein the DNA sequence encoding the antibody variable region further comprises an inducible promoter.

11. The vector of claim 10 , wherein the inducible promoter regulates expression of the DNA sequence encoding the antibody variable region.

12. The vector of claim 1 , wherein the DNA sequence encoding the antibody variable region further comprises an amber stop codon.

13. The vector of claim 12 , wherein the amber stop codon is located between the antibody variable region and the fragment of the wild-type PIII anchor.

14. The vector of claim 1 , wherein the vector is phage or phagemid.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2015
From: LFRP INVESTORS, L.P.
To: DYAX CORP.
Reel/Frame 036902/0703 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2014
From: LADNER, ROBERT C.; COHEN, EDWARD H.; NASTRI, HORACIO G.; ROOKEY, KRISTIN L.; HOET, RENE; HOOGENBOOM, HENDRICUS RENERUS JACOBUS MATTHEUS
To: DYAX CORP.
Reel/Frame 033020/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2014
From: LADNER, ROBERT C.; COHEN, EDWARD H.; NASTRI, HORACIO G.; ROOKEY, KRISTIN L.; HOET, RENE
To: DYAX CORP.
Reel/Frame 032922/0946 →
SECURITY AGREEMENT Recorded Aug 22, 2012
From: DYAX CORP., A DELAWARE CORPORATION
To: LFRP INVESTORS, L.P., A DELAWARE LIMITED PARTNERSHIP
Reel/Frame 028828/0517 →